Skip to main content
An official website of the United States government

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects with a History of Skin Cancer

Research Group
Prostate and Urologic Cancer
Sponsor
University of Alabama at Birmingham
Status
Active, not recruiting
NCT ID
NCT04091022
This is a single institution, randomized, placebo-controlled, double-blind phase IIB trial of 1) topical diclofenac and topical DFMO, or 2) placebo in participants with a history of non melanoma skin cancer/ keratinocytic cancers.
Intervention
Solaraze and Vaniqa
Condition
Non-melanoma Skin Cancer
Investigators
Craug Elmets, MD

See list of participating sites